Conduction defects and arrhythmias in peripheral myopathies;Troubles conductifs et troubles du rythme dans les myopathies périphériques

Archives des Maladies du Coeur et des Vaisseaux

Volumn 97, Issue SPEC. ISS. 4, 2004, Pages 25-33

  Fauchier, L ^a   Babuty, D ^a   Pellieux, S ^a   Toutain, A ^a   Cosnay, P ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE; DIURETIC AGENT; SARCOGLYCAN;

ALGORITHM; ANGIOCARDIOGRAPHY; ATRIOVENTRICULAR BLOCK; BECKER MUSCULAR DYSTROPHY; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DUCHENNE MUSCULAR DYSTROPHY; ELECTROCARDIOGRAPHY; EMERY DREIFUSS MUSCULAR DYSTROPHY; FOLLOW UP; GENE MUTATION; GENETIC VARIABILITY; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HOLTER MONITORING; HUMAN; INCIDENCE; KEARNS SAYRE SYNDROME; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; MYOPATHY; RISK;

ARRHYTHMIA; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HUMANS; MUSCULAR DYSTROPHIES;

EID: 12444297958     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Muntoni F. Cardiomyopathy in muscular dystrophies. Curr Opin Neurol 2003; 16: 577-83.
2. Emery AE. The muscular dystrophies. Lancet 2002; 359: 687-95.
3. McNally E, Allikian M, Wheeler MT et al. Cytoskeletal defects in cardiomyopathy. J Mol Cell Cardiol 2003; 35: 231-41.
4. Sachdev B, Elliott PM, McKenna WJ. Cardiovascular complications of neuromuscular disorders. Curr Treat Options Cardiovasc Med 2002; 4: 171-9.
5. Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc Res 1997; 33: 13-22.
6. Aslanidis C, Jansen G, Amemiya C et al. Cloning of the essential myotonic dystrophy region and mapping or the putative defect. Nature 1992; 355: 548-51.
7. Petkovich NJ, Dunn M, Reed W. Myotonia dystrophica with AV dissociation and Stokes-Adams attacks. Am Heart J 1964; 68: 391-6.
8. Hawley RJ, Gottdiener JS, Gay JA et al. Families with myotonic dystrophy with and without cardiac involvement. Arch Intern Med 1983; 143: 2134-6.
9. Nguyen HH, Wolfe JT, Holmes DR et al. Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. J Am Coll Cardiol 1988; 11: 662-71.
10. Hawley RJ, Milner MR, Gottdiener JS et al. Myotonic heart disease: a clinical follow-up. Neurology 1991; 41: 259-62.
11. Fragola PV, Luzi M, Calo L et al. Cardiac involvement in myotonic dystrophy. Am J Cardiol 1994; 74: 1070-2.
12. Melacini P, Buja G, Fasoli G et al. The natural history of cardiac involvement in myotonic dystrophy: an eight-year follow-up in 17 patients. Clin Cardiol 1988; 11: 231-8.
13. Mathieu J, Allard P, Potvin L et al. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999; 52: 1658-62.
14. Babuty D, Fauchier L, Tena-Carbi D et al. Significance of late ventricular potentials in myotonic dystrophy. Am J Cardiol 1999; 84: 1099-101, A10.
15. Babuty D, Farrokhi T, Casset-Senon D et al. Cardiac condition in myotonic dystrophy. Eur Heart J 2002; 23 (Abstract Suppl.): 257.
16. Lazarus A, Varin J, Onnoughene Z et al. Relationships among electrophysiological findings and clinical status, heart function and extent of DNA mutation in myotonic dystrophy. Circulation 1999; 99: 1041-6.
17. Lazarus A, Varin J, Babuty D, Anselme F, Coste J, Duboc D. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study. J Am Coll Cardiol 2002; 40: 1645-52.
18. Grigg LE, Chan W, Mond HG et al. Ventricular tachycardia and sudden death in myotonic dystrophy: clinical, electrophysiologic and pathologic features. J Am Coll Cardiol 1985; 6: 254-6.
19. Tamura K, Tsuji H, Matsui Y et al. Sustained ventricular tachycardias associated with myotonic dystrophy. Clin Cardiol 1996; 19: 674-7.
20. Merino JL, Carmona JR, Fernandez-Lozano I et al. Mechanisms of sustained ventricular tachycardia in myotonic dystrophy: implications for catheter ablation. Circulation 1998; 98: 541-6.
21. Prystowsky EN, Pritchett EL, Roses AD et al. The natural history of conduction system disease in myotonic muscular dystrophy as determined by serial electrophysiologic studies. Circulation 1979; 60: 1360-4.
22. Lazarus A, Py A, Guerin F et al. Arythmies et syndrome d'apnées obstructives du sommeil de l'adulte. Arch Mal Cœur 1993; 86: 1753-9.
23. Guilleminault C, Stoohs R, Quera-Salva MA. Sleep-related obstructive and nonobstructive apneas and neurologic disorders. Neurology 1992; 42: 53-60.
24. Finsterer J, Stollberger C. The heart in human dystrophinopathies. Cardiology 2003; 99: 1-19.
25. Corrado G, Lissoni A, Beretta S et al. Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 2002; 89: 838-41.
26. Bushby K, Muntoni F, Bourke JP. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul Disord 2003; 13: 166-72.
27. Agretto A, Politano L, Bossone E et al. Pulsed Doppler tissue imaging in dystrophinopathic cardiomyopathy. J Am Soc Echocardiogr 2002; 15: 891-9.
28. Doing AH, Renlund DG, Smith RA. Becker muscular dystrophy-related cardiomyopathy: a favorable response to medical therapy. J Heart Lung Transplant 2002; 21: 496-8.
29. Nolan MA, Jones OD, Pedersen RL, Johnston HM. Cardiac assessment in childhood carriers of Duchenne and Becker muscular dystrophies. Neuromuscul Disord 2003; 13: 129-32.
30. Boriani G, Gallina M, Merlini L et al. Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: a long-term longitudinal study. Stroke 2003; 34: 901-8.
31. Taylor MR, Fain PR, Sinagra G et al. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 2003; 41: 771-80.
32. Durbeej M, Campbell KP. Muscular dystrophies involving the dystropnin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev 2002; 12: 349-61.
33. Fanin M, Melacini P, Boito C et al. LGMD2E patients risk developing dilated cardiomyopathy. Neuromuscul Disord 2003; 13: 303-9.
34. Perocchio M, Tomassini B, Biasia R, Belli Valletta M, Cerutti A, Bobba F. Mitochondrial disease and complete heart block. Kearns-Sayre syndrome. Minerva Med 1992; 83 (Suppl. 1): 7-13.
35. Brais B, Rouleau GA, Bouchard JP, Fardeau M, Tome FM. Oculopharyngeal muscular dystrophy. Semin Neurol 1999; 19: 59-66.